Skip to main content
. 2021 Jan 29;12:687. doi: 10.1038/s41467-021-20907-z

Fig. 2. The number of DMRs in IPNs of different stages by genomic regulatory regions and PMDs.

Fig. 2

The number of DMRs are shown in promoters (a), enhancers (b), transcribed regions (c), repressed regions (heterochromatin) (d), repetitive regions (e), non-repetitive regions (f), inside PMDs (g), and outside PMDs (h). The solid blue dots represent the means of normalized numbers of DMRs in IPNs of each histologic stage with a 95% confidence interval as error bars. The differences among all stages were assessed using the Kruskal-Wallis H test. Source data is provided as a source data file.